AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 289: H1115-H1122, 2005. First published May 20, 2005; doi:10.1152/ajpheart.00086.2005
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/3/H1115    most recent
00086.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thakali, K.
Right arrow Articles by Watts, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thakali, K.
Right arrow Articles by Watts, S. W.

Endothelin-1-induced contraction in veins is independent of hydrogen peroxide

Keshari Thakali, Stacie L. Demel, Gregory D. Fink, and Stephanie W. Watts

Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan

Submitted 28 January 2005 ; accepted in final form 16 May 2005

Reactive oxygen species (ROS), such as superoxide and H2O2, are capable of modifying vascular tone, although the response to ROS can vary qualitatively among vascular beds, experimental procedures, and species. Endothelin-1 (ET-1) induces superoxide production, which can be dismutated to H2O2. The RhoA/Rho kinase pathway partially mediates ET-1-induced contraction and recently was implicated in superoxide-induced contraction. We hypothesized that H2O2, not superoxide, mediates venous ET-1-induced contraction. Rat thoracic aorta and vena cava contracted to exogenously added H2O2 (1 µM–1 mM) [maximum aortic contraction = 10 ± 3% of phenylephrine (10 µM) contraction; maximum venous contraction = 85 ± 13% of norepinephrine (10 µM) contraction]. (+)-(R)-trans-4-(1-aminoethyl-N-4-pyridil)cyclohexanecarboxamide dihydrochloride (Y-27632, 10 µM), a Rho kinase inhibitor, significantly reduced venous H2O2-induced contraction (15 ± 1% of control maximum) and reduced maximum ET-1-induced contraction by 59 ± 1%. However, neither the H2O2 scavenger catalase (100 and 2,000 U/ml) nor cell permeable polyethylene glycol-catalase (163 and 326 U/ml) reduced ET-1-induced contraction in the vena cava. The catalase inhibitor 3-aminotriazole (3-AT) also had no effect on maximal venous ET-1-induced contraction. Basal H2O2 levels were three times higher in the vena cava than in the aorta (vena cava, 0.74 ± 0.09 nmol H2O2/mg protein; aorta, 0.24 ± 0.05 nmol H2O2/mg protein). ET-1 (100 nM) increased H2O2 in the vena cava but not in the aorta (vena cava, 154.10 ± 17.29% of control H2O2; aorta, 83.72 ± 20.20%). Antagonism of either ETA or ETB receptors with the use of atrasentan (30 nM) or BQ-788 (100 nM), respectively, reduced ET-1 (100 nM)-induced increases in venous H2O2. In summary, ET-1 increased H2O2 in veins but not arteries, and venous ET-1-induced H2O2 production was independent of the contractile properties of ET-1.

venous contractility; reactive oxygen species



Address for reprint requests and other correspondence: K. Thakali, B445 Life Sciences Bldg., Dept. of Pharmacology and Toxicology, Michigan State Univ., E. Lansing, MI 48824-1317 (e-mail: thakalik{at}msu.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Just, C. L. Whitten, and W. J. Arendshorst
Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA and ETB receptors
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F719 - F728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Chen, K. Patel, S. G. Connors, M. Mendonca, W. J. Welch, and C. S. Wilcox
Acute antihypertensive action of Tempol in the spontaneously hypertensive rat
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3246 - H3253.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. Szasz, K. Thakali, G. D. Fink, and S. W. Watts
A Comparison of Arteries and Veins in Oxidative Stress: Producers, Destroyers, Function, and Disease
Experimental Biology and Medicine, January 1, 2007; 232(1): 27 - 37.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
A. N. Lyle and K. K. Griendling
Modulation of vascular smooth muscle signaling by reactive oxygen species.
Physiology, August 1, 2006; 21: 269 - 280.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
N. Ardanaz and P. J. Pagano
Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction.
Experimental Biology and Medicine, March 1, 2006; 231(3): 237 - 251.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Thakali, L. Davenport, G. D. Fink, and S. W. Watts
Pleiotropic Effects of Hydrogen Peroxide in Arteries and Veins From Normotensive and Hypertensive Rats
Hypertension, March 1, 2006; 47(3): 482 - 487.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. K. Lund, S. L. Peterson, G. S. Timmins, and M. K. Walker
Endothelin-1-Mediated Increase in Reactive Oxygen Species and NADPH Oxidase Activity in Hearts of Aryl Hydrocarbon Receptor (AhR) Null Mice
Toxicol. Sci., November 1, 2005; 88(1): 265 - 273.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.